Shlomi Madar

Shlomi Madar, Ph.D, is the VP of Life Science Solutions at Signals Analytics, a Decision Science as a Service company, that enables global organizations to continuously experience the “aha moment” through Signals Playbook™, a cloud-based analytical intelligence platform that transforms the world’s unconnected data into actionable insights to enhance customer experience, optimize product portfolio health and propel innovation. He serves as a Subject Matter Expert and Account Executive specializing in technology and innovation accounts for leading pharmaceutical companies. He has designed, developed and overseen dozens of implementations in the fields of Medical Devices and Pharma for clients such as Johnson & Johnson, Bayer, 3M, and TEVA.
Find me on:

Recent Posts

Top Four Trends In Diabetes Technology Today: Recap ATTD Conference

Posted by Shlomi Madar

Last week I attended the Advanced Technologies & Treatments for Diabetes Conference, in Milan, Italy, which brought together the world’s leading researchers, clinical practitioners and corporate professionals for a lively exchange of innovative ideas related to digital health technologies in diabetes. Here are the four top diabetes technology trends as I see it, which I think captures the trends in the diabetes ecosystem at large.

Jan 03, 2017

Forget Therapeutics—How CRISPR Can Redefine the GMO Stigma

Posted by Shlomi Madar

There’s no doubt that CRISPR has the potential to completely transform genome editing and biology as a whole. According to Bruce Conklin of the Gladstone Institutes, “In the past, it was a student’s entire Ph.D. thesis to change one gene. CRISPR just knocked that out of the park.” 

Nov 03, 2016